NCT00034138 - A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

December 31, 2007

Conditions

Ovarian Neoplasms

Interventions

DRUG

oregovomab

Trial Locations (8)

Magee-Women's Hospital, Pittsburgh

Mary Babb Randolph Cancer Center, Morgantown

Walt Disney Memorial Cancer Institute, Orlando

Women's Cancer Research Foundation, Miami

Baptist Hospital of East Tennessee, Knoxville

St. Joseph's Medical Center, South Bend

University of Iowa Hospitals and Clinics, Iowa City

MD Anderson Cancer Center, Houston